Listed

Stepan Co: Form 10-Q for the period ended Mar 31, 2013

Filed with the SEC on May 2, 2013 and accepted by EDGAR at May 2, 2013, 16:51 ET.

Share

Management's discussion and analysis

As filed, 40,465 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.

The matters discussed in the following discussion and analysis include forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.

Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

  • Surfactants – Surfactants, which accounted for 74 percent of consolidated net sales in the first quarter of 2013, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Other applications include germicidal quaternary compounds, lubricating ingredients, emulsifiers (for spreading agricultural products), plastics and composites and biodiesel. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and two Asian sites (Philippines and Singapore). The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields (enhanced oil recovery). The joint venture is accounted for under the equity method, and its financial results are excluded from surfactant segment operating results. Profits on sales of the Company’s surfactants to enhanced oil recovery customers are included in surfactants segment results.
  • Polymers – Polymers, which accounted for 21 percent of consolidated net sales in the first quarter of 2013, include two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of rigid laminate insulation board and panels for thermal insulation in the construction industry and are also a base raw material for flexible foams and coatings, adhesives, sealants and elastomers (collectively CASE products). Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, phthalic anhydride is used internally in the production of polyols. In the U.S., polymer product lines are manufactured at the Company’s Millsdale, Illinois, site. In Europe, polyols are manufactured at the Company’s subsidiaries in Germany and Poland. In Asia, polyols are produced at the Company’s 80-percent owned joint venture in Nanjing, China (see the ‘Segment Results’ section of this MD&A for a discussion regarding the Company’s requirement to move its China facility).
  • Specialty Products – Specialty products, which accounted for 5 percent of consolidated net sales in the first quarter of 2013, include flavors, emulsifiers and solubilizers used in the food and pharmaceutical industries. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.

Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:

(In millions)

Income (Expense) For the Three Months Ended March 31 2013 2012 Change
Deferred Compensation (Administrative expense) ($4.9) ($3.5) ($1.4 ) (1)
Realized/Unrealized Gains on Investments (Other, net) 0.8 1.3 (0.5)
Investment Income (Other, net) 0.1 — 0.1
Pretax Income Effect ($4.0) ($2.2) ($1.8)

(1) See the Corporate Expenses section of this management’s discussion and analysis for details regarding the quarter-over-quarter change in deferred compensation expense.

Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the quarter-over-quarter changes in consolidated net sales and various income line items between the quarters ended March 31, 2013 and 2012:

(In millions)

Three Months Ended March 31 2013 2012 (Decrease) (Decrease) Due to Foreign Translation
Net Sales $456.5 $465.3 ($8.8) ($0.3)
Gross Profit 72.7 76.8 (4.1) (0.2)
Operating Income 28.3 35.4 (7.1) (0.1)
Pretax Income 25.3 32.7 (7.4) (0.1)

RESULTS OF OPERATIONS

Three Months Ended March 31, 2013 and 2012

Summary

Net income attributable to the Company for the first quarter of 2013 declined 15 percent quarter-over-quarter to $19.0 million, or $0.83 per diluted share, compared to $22.3 million, or $0.98 per diluted share, for the first quarter of 2012 (all per share data reflect the effects of the two-for-one common stock split that was effective December 14, 2012). Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first quarter of 2013 follows the summary.

Consolidated net sales declined $8.7 million, or two percent, quarter over quarter. Lower average selling prices and the effects of foreign currency translation accounted for approximately $21.3 million and $0.3 million, respectively, of the decrease. The drop in average selling prices reflected decreased quarter-over-quarter raw material costs for surfactants. A three percent increase in sales volume mitigated the quarter-over-quarter net sales decline by $12.9 million. The surfactants segment accounted for all of the sales volume improvement, growing five percent quarter over quarter. Sales volumes for the polymers and specialty products segments declined seven percent and three percent, respectively.

Operating income for the first quarter of 2013 declined $7.1 million, or 20 percent, from operating income reported for the first quarter of 2012. Gross profit fell $4.1 million, or 5 percent, as all three segments posted lower quarter-over-quarter results. Surfactants gross profit was negatively affected by lower unit margins, while decreased sales volume led to reduced profits for polymers. Lower volumes and unit margins unfavorably impacted specialty products gross profit.

Operating expenses increased $3.0 million, or seven percent, between quarters. Deferred compensation expense accounted for $1.4 million of the increase. The following summarizes the quarter-over-quarter changes in the individual income statement line items that comprise the Company’s operating expenses:

  • Administrative expenses increased $2.4 million, or 14 percent, quarter over quarter. The largest factor for the rise in expense was a $1.4 million increase in expense related to the Company’s deferred compensation plans. An increase in the value of Company stock led to the higher deferred compensation expense. See the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details. Higher expenses for U.S. expatriate support, salaries and software maintenance accounted for the balance of the administrative expense increase.
  • Selling expenses increased less than $0.1 million, or less than one percent, quarter over quarter.
  • Research, development and technical service expenses were up $0.5 million, or five percent, quarter over quarter. Higher salary expenses and product registration expenses for various European directives accounted for the increase.

Net interest expense for the first quarter of 2013 was down $0.4 million, or 16 percent, over net interest expense for the first quarter of 2012. Lower average debt levels, due primarily to scheduled debt repayments made between quarters, led to the decline.

The loss from the Company’s 50-percent equity joint venture (TIORCO) increased $0.3 million quarter over quarter primarily due to lower commission and technical service income.

Other, net was $0.6 million of income for the first quarter of 2013 compared to $1.1 million of income for the same period of 2012. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets was $1.0 million in the first quarter of 2013 compared to $1.5 million in last year’s first quarter, which accounted for the quarter-over-quarter change in the other, net line. Foreign exchange losses totaled $0.4 million for the first quarters of both 2013 and 2012.

The effective tax rate was 24.8 percent for the first quarter of 2013 compared to 31.7 percent for the first quarter of 2012. The decrease was primarily attributable to the federal research and development tax credit and the small agri-biodiesel producer tax credit which were extended retroactively from January 1, 2012, through December 31, 2013, when The American Taxpayer Relief Act of 2012 was signed into law on January 2, 2013. As a result of this legislation, the Company recorded a tax benefit of $1.4 million in the first quarter of 2013 for amounts generated in 2012 and a tax benefit of $.4 million for amounts generated in 2013.

Segment Results

(In thousands)

For the three months ended March 31, 2013 Surfactants Polymers Specialty Products Segment Results Corporate Total
Net sales $339,973 $95,998 $20,575 $456,546 — $456,546
Operating income 29,652 10,764 2,832 43,248 (14,954) 28,294
For the three months ended March 31, 2012
Net sales $347,156 $96,749 $21,364 $465,269 — $465,269
Operating income 32,992 11,751 3,895 48,638 (13,238) 35,400

Surfactants

Surfactants net sales for the first quarter of 2013 declined $7.2 million, or two percent, over net sales for the first quarter of 2012. A seven percent drop in average selling prices and the effects of foreign currency translation accounted for $23.6 million and $0.6 million, respectively, of the net sales decline. Decreases in raw material costs led to the reductions in selling prices. A five percent increase in sales volume favorably affected the net sales change by $17.0 million. A quarter-over-quarter comparison of net sales by region follows:

(In thousands)

For the Three Months Ended March 31, 2013 March 31, 2012 Increase (Decrease) Percent Change
North America $211,462 $224,517 $(13,055) -6
Europe 78,183 75,651 2,532 +3
Latin America 38,202 39,230 (1,028) -3
Asia 12,126 7,758 4,368 +56
Total Surfactants Segment $339,973 $347,156 $(7,183) -2

Net sales for North American operations declined six percent due to a seven percent decrease in average selling prices, partially offset by the effects of a one percent increase in sales volume. The decrease in average selling prices accounted for $15.4 million of the quarter-over-quarter net sales decline. Lower quarter-over-quarter raw material costs led to the decline in average selling prices. The increase in sales volume offset the impact of reduced selling prices by $2.4 million. Increased sales of functional surfactants used in agricultural applications and biodiesel accounted for the increased sales volume.

Net sales for European operations increased three percent due to a seven percent increase in sales volume, partially offset by a three percent decline in average selling prices. The improvement in sales volume contributed $5.3 million of quarter-over-quarter net sales growth. Increased demand for Company products used in personal care and laundry and cleaning products drove the higher sales volume. The decline in average selling prices offset the effect of the higher sales volume by $2.8 million. Decreased raw material costs pushed selling prices lower between quarters.

Net sales for Latin American operations declined three percent as a result of a four percent decrease in average selling prices and the unfavorable effects of foreign currency translation, which accounted for $1.5 million and $1.1 million, respectively, of the quarter-over-quarter net sales change. Lower raw material costs led to the decline in average selling prices. Sales volume improved four percent, the effects of which offset the negative impacts of reduced selling prices and currency translation by $1.6 million. Sales volume for the Brazil subsidiary increased five percent quarter over quarter, as the Company continued to expand its surfactants franchise in that country.

Net sales for Asia operations increased 56 percent due to increased sales volume in the region, primarily in the Philippines.

Surfactants operating income for the first quarter of 2013 declined $3.3 million, or 10 percent, from operating income for the first quarter of 2012. Gross profit decreased $2.3 million principally due to lower average margins that more than offset the effect of higher sales volume. The effects of foreign currency translation contributed $0.3 million to the gross profit decline. Operating expenses increased $1.0 million, or five percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended March 31, 2013 March 31, 2012 Increase (Decrease) Percent Change
North America $39,474 $42,252 $(2,778) -7
Europe 6,869 8,018 (1,149) -14
Latin America 5,492 3,932 1,560 +40
Asia (187) (219) 32 +15
Total Surfactants Segment $51,648 $53,983 $(2,335) -4
Operating Expenses 21,996 20,991 1,005 +5
Operating Income $29,652 $32,992 $(3,340) -10

North American gross profit declined seven percent quarter over quarter due to a decline in average unit margins that more than offset the one percent increase in sales volume. The lower unit margins were due in large part to the falling selling prices (precipitated by declining commodity raw material costs) that occurred at a time when previous, more expensive inventory purchases were still on hand, especially for the Company’s laundry and cleaning products.

Gross profit for European operations declined 14 percent despite a seven percent increase in sales volume. The decline in gross profit reflected lower unit margins, particularly for personal care and laundry and cleaning products.

Gross profit for Latin American operations increased 40 percent due to increased margins and sales volume. Lower raw material costs and a more favorable mix of sales led to the increased margins. The effects of foreign currency translation reduced the quarter-over-quarter gross profit increase by $0.3 million.

The quarter-over-quarter loss at the gross profit line for Asia operations declined 15 percent due to improved sales volume.

Operating expenses for the surfactants segment were up $1.0 million, or five percent, quarter over quarter. Selling, research and development, and administrative expenses were up $0.5 million, $0.3 million and $0.3 million, respectively, quarter over quarter. All three expense categories reflected staffing level increases made throughout 2012 to support the Company’s growth initiatives. In addition, the higher research and product development expenses reflected $0.2 million of increased product registration expenses related to various European directives. The effects of foreign currency translation reduced the operating expense increase by $0.1 million.

Polymers

Polymers net sales for the first quarter of 2013 declined $0.8 million, or one percent, from net sales for the first quarter of 2012. A seven percent decrease in sales volume negatively affected quarter-over-quarter net sales by $6.7 million. Prior year’s North America polyol sales volume was unusually strong due in part to mild late winter and early spring weather. Higher average selling prices and the effects of foreign currency translation offset the effect of the sales volume decline by $5.6 million and $0.3 million, respectively. A quarter-over-quarter comparison of net sales by region is displayed below:

(In thousands)

For the Three Months Ended March 31, 2013 March 31, 2012 Increase (Decrease) Percent Change
North America $60,059 $60,624 $(565) -1
Europe 33,050 32,029 1,021 +3
Asia and Other 2,889 4,096 (1,207) -29
Total Polymers Segment $95,998 $96,749 $(751) -1

Net sales for North American operations declined one percent due to a seven percent decrease in sales volume, partially offset by a seven percent increase in average selling prices. The effect of the sales volume decline reduced quarter-over-quarter net sales by $4.4 million. The increase in average selling prices, which was driven by increased raw material costs, offset the effect of decreased sales volume by $3.8 million. Sales volumes for phthalic anhydride decreased twelve percent due to weaker demand from polyester resin customers. Polyol sales volume dropped four percent primarily due to lower sales to rigid insulation board customers. As previously noted, the prior year’s polyol sales volume was unusually strong.

Net sales for European operations increased three percent due to a six percent increase in average selling prices and to the effects of foreign currency translation, which accounted for $1.7 million and $0.3 million, respectively, of the net sales improvement. Raw material cost increases led to the higher average selling prices. Sales volume declined three percent, which reduced the quarter-over-quarter increase in net sales by $1.0 million. Lower demand due to an uncertain economy led to the decrease in sales volume.

Net sales for Asia and Other operations declined 29 percent quarter over quarter due to a 33 percent decrease in sales volume. The drop in sales volume was attributable to a winding down of manufacturing operations at the Company’s China location coupled with a softening China economy. As noted in prior filings, local government officials in Nanjing, China, have informed the Company that its manufacturing facility in that city will need to be relocated. The Company’s intention is to build a new facility, projected to be operational in 2015, in the Nanjing Chemical Industrial Park. There will be a period of time for which the existing plant will be out of service while the new plant is under construction. During that period, customers’ requirements will be sourced from inventory produced in advance of the shutdown and from other Company plants or third party manufacturers, which will negatively affect profits.

Polymer operating income for the first quarter of 2013 decreased $1.0 million, or eight percent, from operating income for the first quarter of 2012. Gross profit declined $0.9 million quarter-over-quarter, largely due to a seven percent decrease in sales volume. Operating expenses increased $0.1 million, or two percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended March 31, 2013 March 31, 2012 Increase (Decrease) Percent Change
North America $11,411 $11,786 $(375) -3
Europe 5,137 5,364 (227) -4
Asia and Other 3 267 (264) -99
Total Polymers Segment $16,551 $17,417 $(866) -5
Operating Expenses 5,787 5,666 121 +2
Operating Income $10,764 $11,751 $(987) -8

Gross profit for North American operations declined three percent due to the seven percent decrease in sales volume. Improved average unit margins partially offset the effect of the sales volume decline.

Gross profit for European operations declined four percent primarily due to the three percent decrease in sales volume. Slightly lower unit margins, due to higher raw material costs, also contributed to the gross profit decline.

The decline in gross profit for Asia and Other operations was due to the 33 percent decrease in sales volume and to higher expenses. As a result of the need to vacate the current manufacturing facility in China, the Company accelerated depreciation on all assets that were not projected to be moved to the new site. The Company is assuming a June 2013 vacate date. The accelerated depreciation did not have a significant effect on first quarter 2013 polymer profits.

Specialty Products

Net sales for the first quarter of 2013 declined $0.8 million, or four percent, from net sales for the first quarter of 2012. A three percent decrease in sales volume and a decline in selling prices led to the drop in net sales. Operating income declined $1.1 million, or 27 percent, quarter over quarter due to lower sales volume and higher raw material costs.

Corporate Expenses

Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, increased $1.7 million (13 percent) to $14.9 million for the first quarter of 2013 from $13.2 million for the same quarter of 2012. The quarter-over-quarter increase in corporate expenses was principally attributable to a $1.4 million increase in deferred compensation expense ($4.9 million for the first quarter of 2013 compared to $3.5 million for the first quarter of 2012). Increases in the value of Company stock, to which a substantial portion of the deferred compensation obligation is tied, led to the higher quarter-over-quarter deferred compensation expense. The value of Company stock increased $7.56 per share for the first quarter of 2013 compared to $3.82 per share for the first quarter of 2012. The accounting for the Company’s deferred compensation plans results in expense when the values of Company common stock and mutual fund investment assets held for the plans increase and income when the values of Company common stock and mutual funds decline. The following table presents the quarter end Company common stock market prices used in the computation of deferred compensation expense:

2013 3/31 2012 12/31 3/31 2011 12/31
Company Stock Price $63.10 $55.54 $43.90 $40.08

LIQUIDITY AND CAPITAL RESOURCES

For the first quarter of 2013, operating activities consumed $9.9 million, investing activities consumed $22.9 million and non-debt financing activities consumed $1.1 million. To meet these requirements, the Company reduced cash by $22.1 million and increased its debt by $12.4 million. Exchange rates had the effect of reducing cash by $0.6 million for the quarter.

For the current year-to-date, net income decreased by $3.4 million and working capital consumed $13.7 million more than during the comparable year-ago period. Cash used in investing activities increased by $0.5 million year over year. Cash provided by financing activities totaled $11.3 million for the current year period versus a use of $2.5 million for the comparable period in 2012.

For the first quarter of 2013, accounts receivable were a $31.8 million use versus a $23.3 million use for comparable period in 2012. Inventories were a use of $16.5 million in 2013 versus a use of $23.2 million in 2012. Accounts payable and accrued liabilities were a source of $5.5 million in 2013 versus a source of $18.1 million in 2012.

During the first quarters of both 2013 and 2012, the change in raw material costs had little effect on working capital. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Fluctuations in raw material costs translate directly to inventory carrying costs and indirectly to customer selling prices and accounts receivable.

The current year accounts receivable cash use was driven by first quarter 2013 net sales that exceeded fourth quarter 2012 net sales, similar to that of the comparable year-ago quarter. Accounts receivable turnover did not change significantly between December 31, 2012, and March 31, 2013, and was not a significant factor in the year-over-year cash flow comparisons. The year-to-date inventory cash use was driven mainly by higher quantities to support customer service levels for the U.S. and for the China polymer plant relocation. The Company has not changed its own payments practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during the remainder of 2013.

Investing cash outflows for the first quarter of 2013 totaled $22.9 million versus $22.4 million for the comparable period in 2012. Capital expenditures for the current year period totaled $21.0 million compared to $21.3 million for the first quarters of 2012. Other investing activities consumed $1.9 million in the first quarter of 2013 compared to $1.1 million in the first quarter of 2012.

For 2013, the Company estimates that capital expenditures will range from $110 million to $115 million including capacity expansions in Brazil, Germany, China and the United States.

The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. The Company made no open market share repurchases during the first quarter of 2013. At March 31, 2013, there were 1,000,000 shares remaining under the current share repurchase authorization.

As of March 31, 2013, the Company’s cash totaled $54.8 million, including U.S. demand deposits totaling $9.8 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaling $45.0 million.

Consolidated debt increased by $11.5 million for the current year to date, from $182.4 million to $193.9 million with increases of $8.9 million in foreign debt and $2.6 million in domestic debt. Net debt (which is defined as total debt minus cash) increased by $33.6 million for the current year to date, from $105.5 million to $139.1 million. As of March 31, 2013, the ratio of total debt to total debt plus shareholders’ equity was 28.2 percent compared to 27.5 percent at December 31, 2012. As of March 31, 2013, the ratio of net debt to net debt plus shareholders’ equity was 21.9 percent compared to 18.0 percent at December 31, 2012.

As of March 31, 2013, the Company’s debt included $152.1 million of unsecured private placement loans with maturities extending from 2013 through 2023. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

The Company has a committed $125.0 million multi-currency revolving credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, and four other U.S. banks. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time, for working capital and other corporate purposes. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through September 20, 2017, with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of March 31, 2013, the Company had borrowings of $2.6 million and outstanding letters of credit of $2.9 million under this agreement, with $119.5 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future. In addition, the Company believes it has sufficient cash available on hand and through its committed revolving credit agreement to fund the acquisition of the North American Polyester Resins business from Bayer Material Science (See the “Acquisition” discussion in this MD&A and Note 15 to the condensed consolidated financial statements for additional information regarding the acquisition agreement).

Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At March 31, 2013, the Company’s European subsidiaries had bank term loans of $7.7 million with maturities through 2016 and short-term bank debt of $20.5 million with remaining short-term borrowing capacity of $13.6 million. The Company’s Latin American subsidiaries had no short-term bank debt with $10.5 million of unused short-term borrowing capacity. The Company’s Philippine subsidiary had $5.2 million of short-term bank loans, which were guaranteed by the Company, with $2.8 million of unused borrowing capacity. The Company’s majority-owned joint venture in China had short-term bank debt of $5.8 million, with unused borrowing capacity of $0.7 million, on bank credit lines guaranteed by the Company.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of the Company, Stepan Canada Inc., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:

1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.

2. The Restricted Group must maintain net worth of at least $275.0 million.

3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.

4. The Restricted Group may pay dividends and purchase treasury shares after December 31, 2011, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after June 30, 2012. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 12, Debt, in the Notes to Consolidated Financial Statements.

The Company believes it was in compliance with all of its loan agreements as of March 31, 2013. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2013.

ENVIRONMENTAL AND LEGAL MATTERS

The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first three months of 2013 and 2012, the Company’s expenditures for capital projects related to the environment were $1.5 million and $0.4 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $4.1 million and $4.4 million for the three months ended March 31, 2013 and 2012, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $10.2 million to $29.0 million at March 31, 2013, compared to $10.3 million to $28.9 million at December 31, 2012. At March 31, 2013, and December 31, 2012, the Company’s accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $15.3 million and $15.4 million, respectively. During the first three months of 2013, cash outlays related to legal and environmental matters approximated $0.6 million compared to $0.8 million for the first three months of 2012.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

ACQUISTION

On April 30, 2013, the Company announced it had reached an agreement to acquire the North American Polyester Resins business from Bayer Material Science (Bayer), a leading North American producer of powder polyester resins for metal coating applications and liquid polyester resins for CASE applications. The acquisition is to include a 21,000-ton production facility in Columbus, Georgia. The facility also houses a modern research and development laboratory for customer technical support and new product development. The business to be acquired has annual sales of approximately $64 million. Closing of the transaction is subject to customary closing conditions and is expected to occur within four to six weeks. Financial terms of the transaction were not disclosed.

The Company is a leading producer of polyester polyol used in rigid insulation foam. The acquisition is expected to diversify the Company’s polyol product offering and accelerate Company growth in CASE and PUSH (polyurethane systems house) applications. The Company intends to make future capital expenditures to expand production capabilities at the site.

OUTLOOK

Management will continue to execute its strategy to improve Company sales mix with higher value added products, while also pursuing geographic expansion of the Company’s business.

Surfactants should experience improved margins as the year progresses. Recent declines in commodity raw material prices should help recover some of the margin erosion. Surfactants should continue to benefit over the long term from improved product mix and global growth. Agricultural surfactants continue to deliver strong volume growth. Brazil continues to deliver earnings growth. The Company plans additional investments to support Brazilian market growth.

Polymers volume should improve in the second quarter. The slow start to the construction season brought on by protracted winter weather adversely affected first quarter volume. Price increases were implemented during April to recover higher raw material costs.

The announced acquisition of the polyester resins business from Bayer should help diversify and grow the Company’s polyol business. The acquisition should be slightly accretive to 2013 earnings. The lower first quarter results will challenge the Company to deliver full year earnings growth in 2013. Management remains confident that its strategy will deliver long-term earnings growth. The Company continues to evaluate additional investments that can accelerate growth and deliver value to its shareholders.

CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2012 Annual Report on Form 10-K.

Controls and procedures

As filed, 729 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a. Evaluation of Disclosure Controls and Procedures

Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of March 31, 2013.

b. Changes in Internal Control Over Financial Reporting

There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-01-01 to 2013-03-31$456.5mus-gaap:SalesRevenueNet
Cost of revenue3 months2013-01-01 to 2013-03-31$383.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2013-01-01 to 2013-03-31$72.7mus-gaap:GrossProfit
Operating income3 months2013-01-01 to 2013-03-31$28.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-01-01 to 2013-03-31$2.2mus-gaap:InterestExpense
Income tax3 months2013-01-01 to 2013-03-31$6.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-01-01 to 2013-03-31$19.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-01-01 to 2013-03-31$0.83us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-01-01 to 2013-03-31$0.85us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-01-01 to 2013-03-3122,887,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2013-01-01 to 2013-03-31−$9.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2013-01-01 to 2013-03-31$21.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2013-01-01 to 2013-03-31$3.5mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2013-03-31$54.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-03-31$543.0mus-gaap:AssetsCurrent
Total assetsAt period end2013-03-31$1.01bnus-gaap:Assets
Current liabilitiesAt period end2013-03-31$252.2mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2013-03-31$149.9mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2013-03-31$44.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2013-03-31$493.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-13-196318. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.